Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma

BACKGROUND: Immune checkpoint inhibitors (ICIs) are the standard of care for metastatic cutaneous melanoma (mCM) patients, but their efficacy in young adults aged less than 40 years remains unclear. MATERIALS AND METHODS: We retrospectively analyzed 303 stage IV melanoma patients of different ages t...

Descripción completa

Detalles Bibliográficos
Autores principales: Machiraju, Devayani, Schäfer, Sarah, Beckhove, Philip, Roth, Jasmin, Schulz, Carsten, Hassel, Jessica C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899839/
https://www.ncbi.nlm.nih.gov/pubmed/36756176
http://dx.doi.org/10.3389/fmed.2023.1117816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899839/
https://www.ncbi.nlm.nih.gov/pubmed/36756176
http://dx.doi.org/10.3389/fmed.2023.1117816

Ejemplares similares